Benzinga | Mar 24, 2021 09:40AM EDT

From BZ Biotech Conference: AcelRX CEO Vincent Angotti Says August 2020 Publication Showed Reduced Opioid Use And Time In Post-Anesthesia Care Unit When Administering DSUVIA

https://www.youtube.com/watch?v=ezt3L9O6KYU&list=PL4k0fH8EgI3bguSp64h2XAlxhf2gkl21A&index=2